Cite
HARVARD Citation
Braun, M. et al. (2017). Biallelic loss of CDKN2A is associated with poor response to treatment in pediatric acute lymphoblastic leukemia. Leukemia & lymphoma. 58 (5), pp. 1162-1171. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Braun, M. et al. (2017). Biallelic loss of CDKN2A is associated with poor response to treatment in pediatric acute lymphoblastic leukemia. Leukemia & lymphoma. 58 (5), pp. 1162-1171. [Online].